ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,756,019 | +1760.2% | 115,300 | +2206.0% | 0.03% | +2600.0% |
| Q1 2024 | $94,400 | -95.9% | 5,000 | -95.8% | 0.00% | -96.8% |
| Q4 2023 | $2,290,090 | +1494.8% | 119,900 | +1398.8% | 0.03% | +1450.0% |
| Q3 2023 | $143,600 | -88.2% | 8,000 | -86.7% | 0.00% | -90.9% |
| Q2 2023 | $1,218,600 | -55.2% | 60,000 | -59.7% | 0.02% | -57.7% |
| Q1 2023 | $2,717,760 | +5375.8% | 149,000 | +6108.3% | 0.05% | +5100.0% |
| Q4 2022 | $49,632 | -99.5% | 2,400 | -99.4% | 0.00% | -99.3% |
| Q2 2022 | $10,425,000 | +125.7% | 411,400 | +181.1% | 0.14% | +155.4% |
| Q1 2022 | $4,619,000 | +315.8% | 146,340 | +225.9% | 0.06% | +51.4% |
| Q2 2020 | $1,111,000 | – | 44,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
| Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
| Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
| PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
| DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
| Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
| Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
| Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |